Table 3. Distribution of HPV subtypes among infected subjects.
HPV type | Classification* | HPV-positive subjects (N=154) | Percentage† |
---|---|---|---|
Single-type infection | |||
HPV16 | HR | 55 | 35.7 |
HPV18 | HR | 40 | 26.0 |
HPV31 | HR | 3 | 1.9 |
HPV33 | HR | 11 | 7.1 |
HPV35 | HR | 1 | 0.6 |
HPV45 | HR | 3 | 1.9 |
HPV52 | HR | 2 | 1.3 |
HPV53 | HR | 2 | 1.3 |
HPV58 | HR | 14 | 9.1 |
HPV66/68‡ | HR | 4 | 2.6 |
HPV73 | HR | 1 | 0.6 |
HPV81 | HR | 4 | 2.6 |
HPV82 | HR | 1 | 0.6 |
Multiple-type infection | |||
HPV16 + HPV18 | HR + HR | 8 | 5.2 |
HPV16 + HPV81 | HR + HR | 1 | 0.6 |
HPV16 + HPV84/26‡ | HR + LR | 1 | 0.6 |
HPV18 + HPV52 | HR + HR | 1 | 0.6 |
HPV18 + HPV58 | HR + HR | 1 | 0.6 |
HPV31 + HPV45 | HR + HR | 1 | 0.6 |
Abbreviations: HR (high-risk HPV type); LR (low-risk HPV type).
Total percentage is not equal to 100.0% due to rounding.
The HPV genotyping kit used could not distinguish between HPV66 and HPV68, and between HPV84 and HPV26.